Glucagon and insulin act cooperatively in the regulation of prandial hepatic glycogen metabolism
Glucagon and insulin act cooperatively in the regulation of prandial hepatic glycogen metabolism
批准号:
10950888
负责人:
Megan Capozzi
金额:
$11.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-08-01 至 2026-07-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Glucagon and insulin are pancreatic hormones that control the glycemic response to fasting and feeding.
Canonically, glucagon is secreted in the fasted state where it stimulates hepatic glycogenolysis and
gluconeogenesis in order to raise glycemia. Conversely, insulin is secreted in response to elevated blood glucose
to stimulate glucose uptake in peripheral tissues. These canonical, opposing effects of glucagon and insulin on
the liver overlook the long understanding that amino acids in mixed nutrient feeding stimulate the islet a-cell to
secrete glucagon. Moreover, our recent work has shown the importance of glucagon-stimulated insulin secretion
to maintaining glucose tolerance. Therefore, the expected response to a physiologic mixed nutrient meal is the
co-secretion of glucagon and insulin into portal circulation. The preliminary data presented herein support the
notion that glucagon and insulin work cooperatively, not antagonistically, to control prandial glucose metabolism.
We hypothesize that glucagon and insulin co-secretion controls hepatic glucose metabolism to allow glucose to
reach the periphery before being stored in the liver. Successful completion of this project will alter our
fundamental understanding of hepatic glucose metabolism and my provide insight for novel therapeutic targets
for the treatment of metabolic disease. Importantly, completion of the proposed aims will support several new
technical and conceptual developments that will provide a foundation for a career as an independent investigator.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Glucagon and insulin act cooperatively in the regulation of prandial hepatic glycogen metabolism
-
批准号:10282671
-
项目类别:
-
资助金额:$12.99万
-
财政年份:2021
-
负责人:Megan Capozzi
-
依托单位:
Glucagon and insulin act cooperatively in the regulation of prandial hepatic glycogen metabolism
-
批准号:10668450
-
项目类别:
-
资助金额:$1.83万
-
财政年份:2021
-
负责人:Megan Capozzi
-
依托单位:
Glucagon and insulin act cooperatively in the regulation of prandial hepatic glycogen metabolism
-
批准号:10455629
-
项目类别:
-
资助金额:$12.84万
-
财政年份:2021
-
负责人:Megan Capozzi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
同源异形盒基因HvVvl介导20E信号通路和insulin信号通路调控茄二十八星瓢虫变态发育的分子机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:潘慧鹏
-
依托单位:
基于稳态吸收和DPP-IV/GLP-1/Insulin通路解析牡蛎肽协同花色苷的降血糖增效机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:陈忠琴
-
依托单位:
CBP/p300-HADH轴在基础胰岛素分泌调节中的作用和机制研究
-
批准号:82370798
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王晓
-
依托单位:
SMC5-NSMCE2功能异常激活APSCs中p53/p16衰老通路导致脂肪萎缩和胰岛素抵抗的机制研究
-
批准号:82371873
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:乔洁
-
依托单位:
Dif/FoxO激活miRNA调节Toll与insulin信号交互促进果蝇免疫代谢平衡的机制研究
-
批准号:32370516
-
项目类别:面上项目
-
资助金额:51万元
-
批准年份:2023
-
负责人:马飞
-
依托单位:
基于多组学解析光环境促Insulin基因甲基化抑制PI3K/ACTBL2延缓近视发展的分子机制
-
批准号:82301246
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:黄煜
-
依托单位:
骨骼肌中胰高血糖素受体的表达及其调控血糖稳态的作用与机制研究
-
批准号:82370820
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王天歌
-
依托单位:
脂肪酸合成通过GDF15/IRS2介导胰岛素抵抗促进血管内皮细胞活化导致脓毒症肺损伤的机制研究
-
批准号:82372203
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:李然然
-
依托单位:
基于sox9/insulin信号途径探讨养精种玉汤合寿胎丸调节PCOS胎盘表观遗传效应的机制
-
批准号:82104915
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:张春仁
-
依托单位:
SUCLA2失调控介导的琥珀酸代谢异常促进巨噬细胞炎性活化及肥胖发生
-
批准号:32000525
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:蒋昊文
-
依托单位: